Guillaume Daniel,
Business Development Manager

Guillaume joined Ridgeline Discovery in 2022 as director of business development in charge of in-licensing, academic collaborations, and procurement activities. He also supports Versant in the formation of new companies.

Prior to Ridgeline Discovery, Guillaume spent 7 years at F. Hoffmann-La Roche enabling externalized discovery and preclinical research in Neuroscience, Immunology, Infectious Diseases and Ophthalmology therapeutic areas.

Guillaume completed a PhD training at the Max Planck for Psychiatry in Munich and a postdoctoral training at the Swiss Tech Institute in Lausanne (EPFL).